SB

Seema Brijesh Singh

Active Director Director DIN 11919377
DIN 11919377 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Seema Brijesh Singh

Seema Brijesh Singh is a Director at Sbs Pharmaceutical Private Limited (since 2026).

DIN 11919377
Primary Designation Director
First Appointment 31 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sbs Pharmaceutical Private Limited U46497MR2026PTC480208
Director31 Aug 20262026Active

Board colleagues of Seema Brijesh Singh

NameDINCompanyDesignation
Brijesh Avadhesh Singh10443035Sbs Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sbs Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Seema Brijesh Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Brijesh Singh

Seema Brijesh Singh currently holds 1 directorship: Sbs Pharmaceutical Private Limited (Director, since 31 Aug 2026).

Seema Brijesh Singh was first appointed on 31 Aug 2026 as Director at Sbs Pharmaceutical Private Limited.

The current boards of Seema Brijesh Singh's companies include Brijesh Avadhesh Singh (Sbs Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available